Phibro Animal Health Corporation to Issue Quarterly Dividend of $0.12 (NASDAQ:PAHC)

Phibro Animal Health Corporation (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, February 3rd. Investors of record on Wednesday, March 4th will be given a dividend of 0.12 per share on Wednesday, March 25th. This represents a c) annualized dividend and a yield of 1.2%. The ex-dividend date is Wednesday, March 4th.

Phibro Animal Health has a dividend payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Research analysts expect Phibro Animal Health to earn $2.10 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 22.9%.

Phibro Animal Health Trading Down 0.5%

PAHC stock traded down $0.21 during mid-day trading on Wednesday, reaching $41.10. The company’s stock had a trading volume of 191,600 shares, compared to its average volume of 197,639. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $46.42. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32. The business’s 50 day moving average price is $39.79 and its 200 day moving average price is $38.04. The company has a market cap of $1.67 billion, a price-to-earnings ratio of 24.79, a price-to-earnings-growth ratio of 1.19 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.15. The company had revenue of $363.89 million during the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. On average, equities research analysts predict that Phibro Animal Health will post 1.95 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Finally, Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 9th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and a consensus price target of $31.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.